top of page
Patents & Licensing
At AnaBioSi-Data Ltd, we translate groundbreaking research into intellectual assets that drive innovation in oncology. Our growing IP portfolio reflects our commitment to real-world impact through science, technology, and strategic partnerships.
Active Patents & Licenses
Licensed Intellectual Property
PCT/US2021/062663
Cancer Therapeutics Using Bosentan in Combination with a Checkpoint Inhibitor
🔹 Sublicense agreement signed on 04.07.2025
🔹 Licensed from Materia Therapeutics Inc. (exclusive licensee of the University of Cyprus)
Future IP Goals / Pipeline
We are actively working on expanding our IP portfolio across diagnostics, therapy prediction models, and novel drug delivery strategies.
bottom of page